Skip to main content

Degradación sinérgica de la huntingtina mutante para tratar la enfermedad de Huntington, pojniendo el foco en enzimas del metabolismo de lípidos

PI23/00455

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i en Salud
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA INVESTIGACION DEL HOSPITAL LA FE
Execution centre INSTITUTO DE INVESTIGACION SANITARIA HOSPITAL LA FE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SIR-2.3/SIRT4 loss enhances proteostasis and neuronal resilience via AMPK-induced autophagy in Huntington's disease models

  • Trujillo Del Río, Cristina
  • Koyuncu, Seda
  • Tortajada Pérez, Julia
  • Collado Pérez, Mar
  • Gómez-Escribano, Ana Pilar
  • Mora, Carlos
  • Neri, Christian
  • Lahoz, Agustín
  • Roca, Marta
  • Millán, José María
  • Sanz Herranz, Yolanda
  • Vilchez, David
  • Del Valle Carranza, Andrea
  • Vázquez-Manrique, Rafael P.
Huntington’s disease (HD) is a neurodegenerative disorder caused by mutations in the huntingtin gene resulting in an extended polyglutamine (polyQ) stretch in the protein, which is prone to aggregation and toxicity. In addition to a proteostasis imbalance, growing evidence highlights the role of mitochondrial dysfunction in HD progression. Here we explore the role of SIR-2.3/SIRT4, a mitochondrial sirtuin, in polyQ-expanded peptides and mutant huntingtin (mHTT) toxicity using C. elegans and mammalian models. Notably, loss of sir-2.3 function results in neuronal protection mediated by AMPK activation and enhanced autophagy. These neuroprotective effects require the transcription factors DAF-16/FOXO and NHR-49, which regulate autophagy and metabolism. To explore the translational potential of these findings, we used soft ATP synthase inhibitors to mimic sir-2.3 ablation, successfully reducing mHTT-induced neuronal toxicity. These results identify the SIRT4-AMPK axis as a critical regulator linking mitochondrial metabolism, autophagy, and neuronal homeostasis in HD. These findings not only advance our understanding of HD pathogenesis but also offer promising therapeutic targets for restoring proteostasis and neuronal resilience capacity against neurodegenerative diseases., This work was funded by grants from the Instituto de Salud Carlos III (ISCIII) (PI20/00114 and PI23/00455) and co-funded by the European Union. JMM holds a Fortalece grant from the ISCIII (PCI2021-122099-2B). ISCIII grants are co-financed by the European Development Regional Fund “A way to achieve Europe” (ERDF). Julia Tortajada-Perez holds a grant from the Generalitat Valenciana and the European Social Fund (CIACIF2022/421). Andrea del Valle Carranza was supported by the MODFAT-HD (PCI2021-122099-2B) grant, funded by MCIN/AEI/https://doi.org/10.13039/501100011033 and by a postdoctoral Marie Skolodowska-Curie fellowship funded by the European Union through the “NextGenerationEU/PRTR” and Agencia Española de Investigación., Peer reviewed, Modelo experimental alternativo-NAM, Organismos alternativos no vertebrados - Invertebrados - Nemátodos. Caenorhabditis